Searchable abstracts of presentations at key conferences in endocrinology

ea0029p627 | Diabetes | ICEECE2012

Clinical experience of gel testosterone in men with diabetes type 2 and late-onset hypogonadism

Vasilkova O. , Mokhort T.

Aim: To study the effect of testosterone replacement treatment in the aging male with T2DM.Material and methods: Twenty-six hypogonadal men with T2DM and late-onset hypogonadism between the age 50–65 years (55.00 (50.00; 58.00)) were treated with a 1% testosterone gel within 12 months.Results: Testosterone levels increased from 4.65 (2.70; 6.10) nmol/l at baseline to 13.65 (12.60; 15.20) nmol/l after 48 weeks of treatment (...